Search hospitals > California > Truckee
Gene Upshaw Memorial Tahoe Forest Cancer Center
Claim this profileTruckee, California 96161
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
128 reported clinical trials
16 medical researchers
Summary
Gene Upshaw Memorial Tahoe Forest Cancer Center is a medical facility located in Truckee, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Gene Upshaw Memorial Tahoe Forest Cancer Center is involved with conducting 128 clinical trials across 273 conditions. There are 16 research doctors associated with this hospital, such as Edward J. Kim, Richard J. Bold, David R. Gandara, and Tianhong Li.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Edward J. KimUniversity of California Davis Comprehensive Cancer Center1 year of reported clinical research
Studies Adenocarcinoma
Studies Cancer
30 reported clinical trials
68 drugs studied
Richard J. BoldGene Upshaw Memorial Tahoe Forest Cancer Center2 years of reported clinical research
Studies Cancer
Studies Breast Cancer
12 reported clinical trials
35 drugs studied
David R. GandaraUniversity of California Davis Comprehensive Cancer Center5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
18 drugs studied
Tianhong LiUniversity of California Davis Comprehensive Cancer Center1 year of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Solid Tumors
11 reported clinical trials
16 drugs studied
Clinical Trials running at Gene Upshaw Memorial Tahoe Forest Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Cancer
Squamous Cell Carcinoma
Colorectal Cancer
Multiple Myeloma
Recurrence
Plasma Cell Neoplasms
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Gene Upshaw Memorial Tahoe Forest Cancer Center?
Gene Upshaw Memorial Tahoe Forest Cancer Center is a medical facility located in Truckee, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. Gene Upshaw Memorial Tahoe Forest Cancer Center is involved with conducting 128 clinical trials across 273 conditions. There are 16 research doctors associated with this hospital, such as Edward J. Kim, Richard J. Bold, David R. Gandara, and Tianhong Li.